drugset / Trial / NCT01298687
Divided Dose of TRAVATAN®
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the incremental dosing of travoprost ophthalmic solution versus once a day dosing of TRAVATAN® in lowering intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Timeline
- Start
- 2011-02
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost | Other / unclassified | 0.00013 % | Other |
| Subject | Travoprost | Other / unclassified | 0.00033 % | Other |
| Subject | Travoprost | Other / unclassified | 0.001 % | Other |
| Subject | Travoprost | Other / unclassified | 0.00267 % | Other |
| Subject | Travoprost | Other / unclassified | 0.004 % | Other |